G2GBIO Inc. (KOSDAQ:456160)
South Korea
· Delayed Price · Currency is KRW 103,400
+13,200 (14.63%)
At close: Mar 6, 2026
G2GBIO Market Cap
G2GBIO has a market cap or net worth of 1.57 trillion as of March 9, 2026.
Market Cap
1.57T
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
103,400.00
Market Cap Chart
Since August 14, 2025, G2GBIO's market cap has increased from 503.30B to 1.57T, an increase of 211.90%. That is a compound annual growth rate of 643.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1,569.81B | 42.69% |
| Dec 30, 2025 | 1,100.18B | 118.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myung In Pharmaceutical LTD. | 905.20B |
| Samyang Biopharm | 689.31B |
| ImmuneOncia Therapeutics | 569.59B |
| HEM Pharma | 535.01B |
| CellBion | 359.28B |
| DAE HWA Pharmaceutical | 250.31B |
| NOVAREX | 225.53B |
| Vivozon Pharmaceutical | 196.71B |